Among emerging evidences underlining the contribution of ET-1 axis to tumor progression is the finding that ET-1 can influence the accumulation of HIF-1α in different cell types, including melanoma, ovarian and breast cancer and lymphatic endothelial cells [16], [25]–[28]. This evidence concerns the gene HIF1A and melanoma.